QuadMedicine, Inc. (KOSDAQ:464490)

Market Cap	162.98B
Revenue (ttm)	13.11B +195.5%
Net Income	-5.49B
EPS	-592.68
Shares Out	11.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	612,893
Average Volume	798,553
Open	14,740
Previous Close	14,760
Day's Range	14,320 - 15,430
52-Week Range	12,460 - 27,150
Beta	n/a
RSI	46.36
Earnings Date	n/a

About QuadMedicine

QuadMedicine, Inc. engages in research, development, and production of healthcare vaccination needles based on the microneedle array patch (MAP). The company develops vaccinations for children living in remote areas to protect them from infectious diseases, such as diphtheria, tetanus, polio, measles, and hepatitis B. The company focuses on technology integration for medical and pharmaceutical microneedle development. It also provides fundamental MAP research through prototyping to MAP production for clinical trials. The company was incorporate...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 464490